GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Decipher Labs Ltd

Decipher Labs Ltd Q2 FY27 Consolidated Net Loss of (1,406.89) Lakhs

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 14 Nov 2026, 04:53 PM IST  ·  BSE ID: dc25ce72-3307-49d7-b02e-7a687fb1f089
View Original BSE Filing (PDF)
💡
In Simple Terms
Decipher Labs Ltd announced its financial results, showing a large consolidated loss and reduced revenue for the latest quarter.
🤖 AI Summary
  • Decipher Labs Ltd reported a consolidated net loss of (1,406.89) Lakhs for the quarter ended 30 September 2026.
  • Consolidated revenue from operations for Q2 FY27 was 306.67 Lakhs, compared to 431.37 Lakhs in Q2 FY26.
  • Standalone net loss for Q2 FY27 stood at (13.69) Lakhs, with revenue from operations at (0.00) Lakhs.
  • Consolidated Consultancy Services segment reported a result of (1,381.57) Lakhs for the quarter.
  • The Board approved the unaudited standalone and consolidated financial results on November 14, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Consolidated Revenue from operations (Q2 FY27)
306.67 Lakhs
Not comparable — limited prior period data.
Consolidated Net Profit/(Loss) for the period (Q2 FY27)
(1,406.89) Lakhs
Not comparable — limited prior period data.
Consolidated Revenue from operations (Half Year FY27)
548.06 Lakhs
Not comparable — limited prior period data.
Consolidated Net Profit/(Loss) for the period (Half Year FY27)
(1,625.36) Lakhs
Not comparable — limited prior period data.
Standalone Revenue from operations (Q2 FY27)
(0.00) Lakhs
Not comparable — limited prior period data.
Standalone Net Profit/(Loss) for the period (Q2 FY27)
(13.69) Lakhs
Not comparable — limited prior period data.
Standalone Revenue from operations (Half Year FY27)
9.81 Lakhs
Not comparable — limited prior period data.
Standalone Net Profit/(Loss) for the period (Half Year FY27)
(21.61) Lakhs
Not comparable — limited prior period data.
🏢 How This Affects the Company
📈
Business Impact
Consolidated revenue from operations decreased to 306.67 Lakhs in Q2 FY27 from 431.37 Lakhs in Q2 FY26, primarily affecting the Consultancy Services segment which reported a result of (1,381.57) Lakhs.
💰
Financial Impact
The company recorded a consolidated net loss of (1,406.89) Lakhs in Q2 FY27, a significant decline from a profit of 2.01 Lakhs in Q2 FY26. Total consolidated expenses sharply increased to 1,713.91 Lakhs.
⚠️
Risk Impact
The substantial consolidated loss and increase in other expenses to 1,432.19 Lakhs for Q2 FY27 indicate significant operational and financial challenges. The overall negative segment results in both Manufacturing & Trading of Pharmaceutical drugs and Consultancy Services highlight business segment underperformance.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, particularly the consolidated net loss of (1,406.89) Lakhs for Q2 FY27.
🔍
Management Signal
The approval of these unaudited results by the Board of Directors signals transparency regarding the company's financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — monitor consolidated revenue and profitability trends.
Updates on Labour Code impact evaluation — assess any financial implications.
Future segment performance — observe recovery in Consultancy Services segment.
HIGH RISK Significant consolidated net losses and substantial decrease in revenue indicate considerable financial and operational challenges.
💡 Investor Takeaway
Decipher Labs Ltd reported a consolidated net loss of (1,406.89) Lakhs for Q2 FY27, down from 2.01 Lakhs profit in Q2 FY26. Consolidated revenue from operations for the quarter stood at 306.67 Lakhs, decreasing from 431.37 Lakhs YoY.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Consolidated net loss of (1,406.89) Lakhs in Q2 FY27, a significant decline from a profit of 2.01 Lakhs in Q2 FY26.
  • Consolidated revenue from operations decreased to 306.67 Lakhs in Q2 FY27 from 431.37 Lakhs in Q2 FY26.
📅 Company Track Record
Decipher Labs Ltd previously informed BSE of a Board Meeting on August 13, 2026, to approve Q1 FY27 financial results and on May 30, 2026, to approve FY26 financial results. These current results indicate a significant deterioration in profitability compared to previous periods.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Decipher Labs Ltd's consolidated net profit/loss for Q2 FY27?
Decipher Labs Ltd reported a consolidated net loss of (1,406.89) Lakhs for the quarter ended 30 September 2026.
What was Decipher Labs Ltd's consolidated revenue from operations for Q2 FY27?
The consolidated revenue from operations for Decipher Labs Ltd in Q2 FY27 was 306.67 Lakhs.
What was Decipher Labs Ltd's standalone net profit/loss for Q2 FY27?
Decipher Labs Ltd reported a standalone net loss of (13.69) Lakhs for the quarter ended 30 September 2026.
How did the Consultancy Services segment perform in Q2 FY27 on a consolidated basis?
The Consultancy Services segment reported a consolidated result (Profit Before Tax & Interest) of (1,381.57) Lakhs for the quarter ended 30 September 2026.
What were the consolidated total expenses for Decipher Labs Ltd in Q2 FY27?
Consolidated total expenses for Decipher Labs Ltd reached 1,713.91 Lakhs for the quarter ended 30 September 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel